Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Heliyon|December 4, 2023
CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26)Ji-Hea Kim, Ka-Won Kang, Yong Park, et al.Stem Cell Research|July 24, 2021
Generation of induced pluripotent stem cell line KUMi002-A with normal karyotype from a patient with Philadelphia chromosome-positive chronic myeloid leukemiaJi-Hea Kim, Ka-Won Kang, Byung-Hyun Lee, et al.Stem Cell Research|July 19, 2021
Generation of the induced pluripotent stem cell line KUMi001-A carrying the Philadelphia chromosome from a chronic myeloid leukemia patientJi-Hea Kim, Ka-Won Kang, Byung-Hyun Lee, et al.Stem Cell Research|July 29, 2022
Generation of human induced iPSC KUMi003-A from acute promyelocytic leukemia (APL) M3Ji-Hea Kim, Ka-Won Kang, Byung-Hyun Lee, et al.Data in Brief|September 9, 2020
Supporting data on enhanced reprogramming of human CD34+ hematopoietic stem cells to induced pluripotent stem cells using human placenta-derived cell conditioned mediumSeung-Jin Lee, Ji-Hea Kim, Ka-Won Kang, et al.Stem Cell Research|July 25, 2020
Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned mediumSeung-Jin Lee, Ka-Won Kang, Ji-Hea Kim, et al.Stem Cell Research|November 3, 2020
Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q deletion and IGH translocationSeung-Jin Lee, Ji-Hea Kim, Ka-Won Kang, et al.Stem Cell Research|November 4, 2022
Generation of the human pluripotent stem cell lines KUMi005-A from a patients with multiple myelomaJi-Hea Kim, Ji-Hyeon Hong, Ka-Won Kang, et al.Biochemical Pharmacology|June 19, 2021
CXCR2, a novel target to overcome tyrosine kinase inhibitor resistance in chronic myelogenous leukemia cellsJi-Hea Kim, Seung-Jin Lee, Ka-Won Kang, et al.Stem Cell Research|January 23, 2022
A human pluripotent stem cell line KUMi004-A generated from a patient with chronic lymphocytic leukemiaJi-Hea Kim, Ka-Won Kang, Byung-Hyun Lee, et al.Pageof 2